We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Formula IV Plus - New , NeoLife International Pty Ltd, CON-1032
Product name
Formula IV Plus - New
Sponsor name
NeoLife International Pty Ltd
ARTG details
Consent start
Consent no.
CON-1032
Duration
The consent is effective from 10 November 2022 until 30 November 2024.
Standard
TGO 92 Standard for labels of non-prescription medicines - subparagraphs 10(8)(a)(vi) and 10(8)(a)(vii) of Therapeutic Goods Order No. 92 - Standard for labels of non-prescription medicines
Non-compliance with standard
The product does not comply because the individual unit wrapper (intermediate
packaging) does not include the names and quantities of all active ingredients
in the medicine.
Conditions imposed
The outer carton (primary packaging) must include a statement indicating that
each individually wrapped unit must be kept inside the carton prior to the time
of consumption. The Company may choose the following statements on your labels
or wordings along those lines.
‘Do not remove from primary packaging before use’; or
‘Store in original outer packaging until use’
Import, Supply, &/or Export
import and supply
Therapeutic product type
Listed complementary medicines